Skip to Main Content

Paper Details

Targeting Transcriptional Regulation with a CDK9 Inhibitor Suppresses Growth of Endocrine- and Palbociclib-Resistant ER+ Breast Cancers.
Cancer Res
0
2024
Author NameAffiliation
Syed HaiderInstitute of Cancer Research
Elisabetta MarangoniInstitute Curie
Clare M IsackeInstitute of Cancer Research
  • 1 - 3

Datasets

Release 1.2